Logo image of ARBE

ARBE ROBOTICS LTD (ARBE) Stock Fundamental Analysis

NASDAQ:ARBE - Nasdaq - IL0011796625 - Common Stock - Currency: USD

1.32  -0.03 (-2.22%)

After market: 1.32 0 (0%)

Fundamental Rating

2

ARBE gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. ARBE has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, ARBE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ARBE had negative earnings in the past year.
In the past year ARBE has reported a negative cash flow from operations.
In the past 5 years ARBE always reported negative net income.
In the past 5 years ARBE always reported negative operating cash flow.
ARBE Yearly Net Income VS EBIT VS OCF VS FCFARBE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M -50M

1.2 Ratios

ARBE has a worse Return On Assets (-74.24%) than 90.32% of its industry peers.
ARBE has a worse Return On Equity (-96.06%) than 84.68% of its industry peers.
Industry RankSector Rank
ROA -74.24%
ROE -96.06%
ROIC N/A
ROA(3y)-77.96%
ROA(5y)-128.86%
ROE(3y)-135.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ARBE Yearly ROA, ROE, ROICARBE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 500 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ARBE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ARBE Yearly Profit, Operating, Gross MarginsARBE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

More info and screens

3

2. Health

2.1 Basic Checks

ARBE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ARBE has more shares outstanding
ARBE has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ARBE has a worse debt to assets ratio.
ARBE Yearly Shares OutstandingARBE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ARBE Yearly Total Debt VS Total AssetsARBE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -2.01, we must say that ARBE is in the distress zone and has some risk of bankruptcy.
ARBE's Altman-Z score of -2.01 is on the low side compared to the rest of the industry. ARBE is outperformed by 84.68% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that ARBE is not too dependend on debt financing.
ARBE has a Debt to Equity ratio (0.13) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Altman-Z -2.01
ROIC/WACCN/A
WACC9.16%
ARBE Yearly LT Debt VS Equity VS FCFARBE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

ARBE has a Current Ratio of 2.63. This indicates that ARBE is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.63, ARBE perfoms like the industry average, outperforming 56.45% of the companies in the same industry.
A Quick Ratio of 2.63 indicates that ARBE has no problem at all paying its short term obligations.
ARBE has a better Quick ratio (2.63) than 67.74% of its industry peers.
Industry RankSector Rank
Current Ratio 2.63
Quick Ratio 2.63
ARBE Yearly Current Assets VS Current LiabilitesARBE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

4

3. Growth

3.1 Past

ARBE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.82%, which is quite good.
ARBE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -35.51%.
ARBE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.11% yearly.
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
Revenue 1Y (TTM)-35.51%
Revenue growth 3Y-30.11%
Revenue growth 5YN/A
Sales Q2Q%-70.8%

3.2 Future

Based on estimates for the next years, ARBE will show a very strong growth in Earnings Per Share. The EPS will grow by 20.58% on average per year.
Based on estimates for the next years, ARBE will show a very strong growth in Revenue. The Revenue will grow by 154.53% on average per year.
EPS Next Y33.31%
EPS Next 2Y19.47%
EPS Next 3Y14.42%
EPS Next 5Y20.58%
Revenue Next Year98.12%
Revenue Next 2Y205.19%
Revenue Next 3Y169.21%
Revenue Next 5Y154.53%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ARBE Yearly Revenue VS EstimatesARBE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M
ARBE Yearly EPS VS EstimatesARBE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.5 -0.5

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ARBE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ARBE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ARBE Price Earnings VS Forward Price EarningsARBE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ARBE Per share dataARBE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

4.3 Compensation for Growth

ARBE's earnings are expected to grow with 14.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.47%
EPS Next 3Y14.42%

More info and screens

0

5. Dividend

5.1 Amount

ARBE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARBE ROBOTICS LTD

NASDAQ:ARBE (8/1/2025, 8:20:55 PM)

After market: 1.32 0 (0%)

1.32

-0.03 (-2.22%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-20 2025-05-20/bmo
Earnings (Next)08-07 2025-08-07/bmo
Inst Owners38.69%
Inst Owner Change0.18%
Ins Owners5.9%
Ins Owner ChangeN/A
Market Cap138.81M
Analysts80
Price Target2.42 (83.33%)
Short Float %7.32%
Short Ratio4.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.56%
Min EPS beat(2)8.09%
Max EPS beat(2)15.03%
EPS beat(4)3
Avg EPS beat(4)5.11%
Min EPS beat(4)-16.42%
Max EPS beat(4)15.03%
EPS beat(8)3
Avg EPS beat(8)-4.02%
EPS beat(12)3
Avg EPS beat(12)-9.17%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-68.26%
Min Revenue beat(2)-75.74%
Max Revenue beat(2)-60.78%
Revenue beat(4)1
Avg Revenue beat(4)-43.64%
Min Revenue beat(4)-75.74%
Max Revenue beat(4)35.16%
Revenue beat(8)1
Avg Revenue beat(8)-49.94%
Revenue beat(12)1
Avg Revenue beat(12)-47.68%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20.83%
EPS NQ rev (1m)12.5%
EPS NQ rev (3m)30%
EPS NY rev (1m)0%
EPS NY rev (3m)27.97%
Revenue NQ rev (1m)-13.33%
Revenue NQ rev (3m)-13.33%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-22.67%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 171.8
P/FCF N/A
P/OCF N/A
P/B 2.11
P/tB 2.11
EV/EBITDA N/A
EPS(TTM)-0.62
EYN/A
EPS(NY)-0.37
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS0.01
BVpS0.62
TBVpS0.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.24%
ROE -96.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-77.96%
ROA(5y)-128.86%
ROE(3y)-135.18%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.92%
Cap/Sales 70.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.63
Quick Ratio 2.63
Altman-Z -2.01
F-Score3
WACC9.16%
ROIC/WACCN/A
Cap/Depr(3y)114.23%
Cap/Depr(5y)128.33%
Cap/Sales(3y)41.35%
Cap/Sales(5y)41.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.82%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.75%
EPS Next Y33.31%
EPS Next 2Y19.47%
EPS Next 3Y14.42%
EPS Next 5Y20.58%
Revenue 1Y (TTM)-35.51%
Revenue growth 3Y-30.11%
Revenue growth 5YN/A
Sales Q2Q%-70.8%
Revenue Next Year98.12%
Revenue Next 2Y205.19%
Revenue Next 3Y169.21%
Revenue Next 5Y154.53%
EBIT growth 1Y-28.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.45%
EBIT Next 3Y14.3%
EBIT Next 5Y22.7%
FCF growth 1Y19.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.18%
OCF growth 3YN/A
OCF growth 5YN/A